Breadcrumb

IQWiG-Autumn-Symposiums from 2006 to 2013

Every year health experts from Germany and abroad meet in Cologne at the IQWiG Autumn Symposium to discuss current issues of the healthcare system. An overview of the topics and presentations from 2006 to 2013 is shown below.

IQWiG Autumn Symposium 2013

Quality of life in health care: Do we know what we are doing?

In the competing fields of patients' interests, legislation and research, the content of the term "quality of life" is interpreted differently, depending on the perspective. "Quality of life in health care: Do we know what we are doing?" – this is what we asked experts from research, medical practice and self-government, as well as patient representatives and other participants at the Autumn Symposium held in Cologne on 29 and 30 November 2013.

Presentations | Meeting programme

IQWiG Autumn Symposium 2012

Cancer: Is everything different? / Can less be more?

Current aspects in medicine and health care were discussed again in Cologne on 23rd and 24th November 2012. This year the speakers at the IQWiG Autumn Symposium posed two controversially discussed questions in health care: "Cancer: Is everything different?” and "Can less be more?”

Presentations | Meeting programme

IQWiG Autumn Symposium 2011

Methodology: between regulations and arbitrariness / Personal responsibility

Current and controversial aspects in medicine and health policy was discussed again in Cologne on 25-26 November 2011. This year the IQWiG Autumn Symposium, which has been taken place for the seventh time, was address the topics "Methodology: between regulations and arbitrariness” and "Personal responsibility”.

Presentations | Meeting programme

IQWiG Autumn Symposium 2010

Balancing of benefits and harms in health system decision-making / Data transparency as a precondition to the informed balancing of benefits and harms

How can the benefits and harms of interventions in different medical areas be balanced against each other? How evidence-based can such a balancing be? How do the approaches to such a balancing of benefits and harms differ from the perspective of the German Drug Law on the one hand and that of the Social Code Book on the other? Which study data are required to be able to actually perform an informed balancing of benefits and harms? For example, how is the development of clinical practice guidelines affected if only part of the study data is available? What about data transparency in the field of medical devices? Leading health care researchers will discuss these and other questions at IQWiG's annual Autumn Symposium in Cologne on 19 and 20 November.

Presentations | Meeting programme

IQWiG Autumn Symposium 2009

Medicine - belief and knowledge / Health care system - experiencing and funding it

What value judgements are made in medical science? How many medical decisions are based on scientific proof, on proven knowledge? Can the pharmaceutical industry carry out objective research? Can we justify any rationing of health resources? What reforms are necessary to improve health care?

Presentations | Meeting programme

IQWiG Autumn Symposium 2008

Assessment of the Benefits and Harms of Medical Interventions / Science, Society, and the Individual

Leading health care experts from home and abroad met again at the IQWiG Autumn Symposium in Cologne on 28 and 29 November to discuss current and controversial aspects of medicine.

The first day focused on a key topic of the Institute: evaluating the benefit and harm of medical interventions. The topic for the second day of the symposium explored the requirements of and consequences for stakeholders in health care on the one hand, and insured citizens and patients on the other, as a result of the scientific knowledge obtained.

Presentations | Meeting programme

IQWiG Autumn Symposium 2007

Knowledge as the basis of physicians' and patients' decision-making / The financial significance of disease and health

Can therapy outcomes be improved if patients are well informed? Which legal aspects need to be considered when informing patients? Why are many drugs so expensive? How are prices for medical services calculated and determined in other countries? Leading health care experts pursued these and other questions in Cologne on 23 and 24 November.

Presentations | Meeting Programme (German Version)

IQWiG Autumn Symposium 2006

Hopes and Errors in Medicine / Costs, Quality and Justice in the Health Care System

About 250 health care experts from Germany and abroad met in Cologne to discuss health care issues. What is the state of quality improvement in the pharmaceutical industry and quality control in medicine? Is the truth bearable? What are the benefits and harms of information for terminally ill patients?

Presentations


Save result list

To save your search result, please copy the link below and paste it into a new tab/window.

close